Healthcare in the United States looks fundamentally different than it did a decade ago. The country now spends $5.3 trillion annually on healthcare, or about $15,474 per person, accounting for 18% of GDP. But that money buys a very different kind of care than it did in 2014: more digital, more personalized, more expensive in some ways, and more accessible in others. Here’s what actually changed.
Telehealth Went From Niche to Normal
In 2014, virtual doctor visits were rare, mostly limited to rural areas with provider shortages and a handful of employer-sponsored programs. The infrastructure existed, but insurance coverage was spotty, regulations were restrictive, and most patients had never considered seeing a doctor through a screen.
COVID-19 changed that almost overnight. When in-person visits became dangerous or impossible in early 2020, emergency regulatory waivers allowed providers to bill for telehealth across state lines and through simple video platforms. Utilization skyrocketed, and while it settled back down after the acute phase of the pandemic, telehealth permanently embedded itself in routine care. Mental health visits, follow-up appointments, prescription refills, and chronic disease check-ins now commonly happen by video or phone. What was once a workaround became a standard option on most clinic scheduling pages.
Artificial Intelligence Entered the Exam Room
The FDA has now cleared over 1,400 AI-enabled medical devices. The vast majority of those approvals came in the last five years, concentrated in radiology, cardiology, and ophthalmology. These tools analyze medical images, flag abnormalities on scans, and help detect conditions like diabetic eye disease or irregular heart rhythms faster than a human reviewer alone.
For patients, this mostly shows up behind the scenes. Your chest X-ray might be triaged by an algorithm before a radiologist reads it. Your smartwatch might detect an irregular heartbeat and prompt you to see a cardiologist. AI hasn’t replaced doctors, but it has become a second set of eyes in many diagnostic workflows, particularly for pattern recognition in imaging.
mRNA Technology Proved Itself
Before 2020, mRNA vaccines had been studied in small clinical trials for diseases like rabies and cytomegalovirus, but none had reached the market. Researchers had spent years solving technical problems: figuring out how to package fragile mRNA molecules in tiny fat particles so they could survive inside the body, and removing impurities that triggered unwanted immune reactions and reduced effectiveness.
The COVID-19 pandemic compressed what might have been another decade of development into roughly 11 months. Two mRNA vaccines received emergency authorization after the viral sequence was published, demonstrating that the platform could move from genetic code to injectable vaccine faster than any previous technology. That speed wasn’t reckless. It reflected years of groundwork that simply hadn’t been tested at scale. Now, mRNA-based vaccines and therapies are in clinical trials for influenza, cancer, and other infectious diseases, and the platform is considered one of the most significant pharmaceutical advances of the decade.
Genetic Testing Became Affordable
In 2014, whole genome sequencing cost several thousand dollars and was largely confined to research settings or patients with rare diseases that justified the expense. By the late 2010s, that price had dropped to around $1,000, and it has continued to fall since. Consumer genetic testing through companies like 23andMe brought a simplified version of genetic analysis to millions of people for under $200.
More meaningfully for clinical care, targeted genetic tests now guide treatment decisions in oncology, cardiology, and pharmacology. Tumor profiling helps oncologists choose therapies based on the specific mutations driving a patient’s cancer rather than just its location in the body. Pharmacogenomic tests can predict whether you’ll metabolize certain medications too quickly or too slowly, helping doctors adjust doses before you experience side effects. Genetics moved from an exotic specialty to a practical clinical tool in under a decade.
Insurance Coverage Expanded, Then Stabilized
The Affordable Care Act’s major coverage provisions took effect in 2014, including Medicaid expansion in participating states and the insurance marketplace with income-based subsidies. The impact on coverage was dramatic. By 2024, 92% of Americans had health insurance for some or all of the year, representing an uninsured rate of about 8%. A decade earlier, that rate was significantly higher, with tens of millions more people lacking any coverage.
Coverage, however, didn’t solve the cost problem. Per capita spending on prescription drugs rose from $974 in 2014 to $1,227 by 2022, an average increase of 3.8% per year. High-deductible plans became more common, meaning many insured Americans still faced significant out-of-pocket costs before their coverage kicked in. Having an insurance card and being able to afford care remained two different things for many families.
Patient Portals Changed How You Access Records
A decade ago, getting your lab results often meant waiting for a phone call from a nurse or requesting paper copies at the front desk. Today, 99% of U.S. hospitals let patients view their health information electronically, and 95% give patients access to their clinical notes, the actual documentation written by their providers. Secure messaging with doctors is available at 92% of hospitals, replacing some of the back-and-forth phone tag that used to define routine medical communication.
More advanced features are still catching up. Only 56% of hospitals let patients import records from other healthcare organizations into their portal, which means your information is still often siloed if you see providers in different health systems. And 62% allow you to submit your own health data, like blood pressure readings or glucose logs, directly into your medical record. The trajectory is clear, though: patients have far more direct access to their own health information than at any previous point.
Provider Burnout Became a Crisis
The demands placed on physicians intensified considerably over the past decade. Electronic health records, which were still being adopted at many institutions in 2014, became universal but brought hours of daily documentation work. Administrative requirements from insurers grew. And then the pandemic hit.
By 2022, roughly 63% of U.S. physicians reported experiencing burnout at least once a week, a figure described as an all-time high. The consequences ripple outward: burned-out doctors are more likely to reduce their hours, leave clinical practice, or make medical errors. Healthcare systems have responded with wellness programs, scribes to handle documentation, and schedule changes, but the structural drivers of burnout, particularly administrative burden, remain largely intact. For patients, this manifests as longer wait times for appointments, shorter visits, and higher turnover among their providers.
Life Expectancy Took a Hit, Then Recovered
U.S. life expectancy followed a jarring trajectory over the past decade. It was already under pressure before 2020 due to rising deaths from drug overdoses, suicide, and chronic liver disease, particularly among middle-aged white Americans. Then COVID-19 drove life expectancy down sharply, erasing years of gains in a matter of months.
By 2024, life expectancy at birth had recovered to 79.0 years for the total U.S. population, reflecting the combination of pandemic recovery, improved treatment options, and declining COVID mortality. But that number masks persistent disparities by race, geography, and income that have widened over the decade. Rural communities, in particular, saw hospital closures and provider shortages accelerate, leaving some Americans farther from emergency care than they were in 2014.
The Bigger Picture
The last decade brought genuine breakthroughs in what medicine can do: faster vaccines, smarter diagnostics, cheaper genetic insights, and more convenient access through telehealth and patient portals. At the same time, the system delivering that care grew more expensive, more administratively burdensome, and harder on the people who work in it. Healthcare in 2025 is more technologically capable than at any point in history. Whether it’s more functional as a system depends largely on who you are, where you live, and what insurance card you carry.